Dr. Schiff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
852 S Robertson Blvd
Los Angeles, CA 90035Phone+1 310-659-9257Fax+1 310-659-9273
Education & Training
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1983 - 1985
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1982 - 1983
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982
Certifications & Licensure
CA State Medical License 1983 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Start of enrollment: 2007 Oct 01
- LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- 11 citationsTreatment of diabetic neuropathy with pentoxifylline: case report.Robert B. Kalmansohn, Richard W. Kalmansohn, Charles H. Markham, David L. Schiff
Angiology. 1988-04-01 - 1 citationsPresent Status of HMG Reductase Inhibitors in Treatment of DyslipidemiaR B Kalmansohn, Richard W. Kalmansohn, David L. Schiff
Angiology. 1998-09-01 - Revised indications for statin therapies.Robert B. Kalmansohn, Richard W. Kalmansohn, David L. Schiff
Angiology. 2001-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
